SEC 13F Intelligence

Viking Global Investors LP / ELV

Viking Global Investors LP’s Elevance Health Inc Formerly Position

Does Viking Global Investors LP own Elevance Health Inc Formerly (ELV)? Not currently — the last reported position was 1.41M shares worth $628M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$628M
Q2 2023
Shares
1.41M
% of Portfolio
+2.57%
Quarters Held
12
position exited

Position History ELV

Reported value by quarter
Q4 ’18: $1.3BQ4 ’18Q1 ’19: $1.8BQ2 ’19: $1.5BQ2 ’19Q3 ’19: $930MQ4 ’19: $932MQ4 ’19Q1 ’20: $411MQ3 ’20: $140MQ3 ’20Q2 ’22: $707MQ3 ’22: $1.1BQ3 ’22Q4 ’22: $960MQ1 ’23: $991MQ1 ’23Q2 ’23: $628Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 20231.41M$628M+2.57%
Q1 20232.15M$991M+4.65%
Q4 20221.87M$960M+4.81%
Q3 20222.34M$1.1B+4.90%
Q2 20221.46M$707M+3.23%
Q3 2020522.4K$140M+0.51%
Q1 20201.81M$411M+2.14%
Q4 20193.09M$932M+4.37%
Q3 20193.87M$930M+4.84%
Q2 20195.20M$1.5B+6.58%
Q1 20196.19M$1.8B+10.19%
Q4 20185.10M$1.3B+7.62%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Viking Global Investors LP’s full portfolio or all institutional holders of ELV.